NJ Weight Loss & Preventive Care

Peptide Therapy

What Each Peptide Does, Why a Physician Would Prescribe It, and What the Evidence Says

This does not constitute an offer to purchase any type of medication.

Verified Sourcing All medications come from FDA-registered U.S. pharmacies. Clinical supplies and select medications ship directly from major licensed distributors like McKesson and Henry Schein — the same wholesalers that supply hospitals and physician offices.
About This Guide
This page explains, in plain English, what each peptide we work with actually does, why a physician would consider prescribing it, and what the published evidence shows. It is a companion to our Peptide Dosing Reference, which contains the clinical dosing tables and titration schedules used by our medical team. All therapies are individualized and require physician evaluation.

Important Disclaimer — Read Before Using This Guide

This assessment and dosing information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide therapy.

All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.

The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any peptide.

Anyone starting a medication they have never taken before should take an extremely conservative approach. Without large-scale, long-term clinical studies, all medications carry the possibility of unknown or unreported side effects.

These materials are provided only to help begin your research. They are not medical advice and should not be used as a substitute for professional medical care.

Nothing in these videos should be taken as medical advice.

If you are considering any peptide therapy, you must consult with a licensed, experienced physician and a licensed, experienced compounding pharmacist.

All dosing and treatment decisions should be made between you and your medical providers after proper evaluation.

We strongly encourage everyone to do their own exhaustive research. The information we are sharing comes from publicly available videos by qualified physicians, published studies, and review of the literature.

We are not affiliated with any of the doctors whose clips appear in these videos.

1. What Are Peptides?

Peptides are short chains of amino acids—the same building blocks that make up proteins. Think of amino acids as individual letters, peptides as short words, and proteins as full sentences. Your body produces thousands of peptides naturally, and they act as chemical messengers that tell your cells what to do.

Different peptides send different signals. Some tell your body to release growth hormone. Some regulate metabolism or appetite. Others support tissue repair, reduce inflammation, or modulate the immune system. They work by binding to specific receptors on your cells and triggering a targeted biological response.

This is not fringe science. Your body already runs on peptides. Insulin is a peptide. Oxytocin is a peptide. The GLP-1 medications many of our patients use (semaglutide, tirzepatide) are peptide-based drugs. Peptide therapy simply means using specific peptides, in precise doses, to support or restore functions your body may not be performing optimally on its own.

2. Peptides Are Not New

Peptide-based medicine has been around for over 100 years. Insulin was first used therapeutically in 1921. Since then, dozens of peptide drugs have been developed, tested, and FDA-approved for conditions ranging from diabetes to osteoporosis to fertility treatment.

What has changed recently is the scope of research. Scientists are now studying peptides for applications in metabolic disease, neurological repair, immune support, anti-aging, muscle recovery, and sexual health. Some are well-established; others are investigational.

At our practice, we only prescribe peptides that have a meaningful evidence base and a clear clinical rationale for the individual patient. We are not chasing trends—we are applying science.

3. Why the Source of Your Peptides Matters

Critical Safety Warning
There is a massive gray market for peptides online. Websites sell them labeled "for research use only," which is a legal workaround to avoid FDA regulation. These products are not tested for purity, sterility, or accurate dosing. Contaminated peptides have caused infections, abscesses, and adverse reactions. Underdosed products waste your money. Overdosed products can cause real harm.

The grey market for peptides is a large online network where consumers buy unregulated, chemical-grade compounds such as BPC-157, TB-500, Melanotan, and unauthorized versions of semaglutide outside medical and pharmacy channels. Valued at more than $100 million, the market often depends on imported bulk materials distributed through alternative retail networks.

Sellers exploit legal loopholes by labeling products “For Research Use Only” or “Not for Human Consumption,” shifting liability to buyers. Despite these warnings, products are packaged in vials with mixing supplies intended for injection. Because banks and credit card companies often block unapproved injectable sales, many sellers accept cryptocurrency.

These peptides carry serious risks because they bypass pharmaceutical regulation. Studies report that 40% to 75% fail basic safety standards, with some containing heavy metals, toxic impurities, or endotoxins. Products may contain incorrect doses, no active peptide, excessive concentrations, or entirely different substances. Users often mix and inject them without medical supervision, risking muscle loss, organ strain, nutritional deficiencies, and severe immune reactions. Women may face additional risks, including copper toxicity from injectable GHK-Cu and possible pregnancy or uterine complications.

Make certain to get peptides through a physician’s office to insure the quality and safety of your purchase.

If someone is selling you peptides without a prescription and without medical oversight—walk away. It is not worth the risk to your health.

4. The Regulatory Landscape Is Changing

The FDA has been paying increasing attention to peptides. Some bulk substances have been categorized as ineligible due to safety concerns. Availability of certain peptides can shift quickly.

5. How Peptides Are Administered

Most peptide therapies are administered via subcutaneous injection—a small needle injected just under the skin, typically in the abdomen or thigh. The needles are tiny (30 or 31 gauge insulin syringes) and most patients report minimal discomfort. Some peptides are also available as oral capsules, nasal sprays, or topical creams. All injectable medications include syringes and ship overnight directly from the pharmacy.

6. What to Expect When Starting Peptide Therapy

Peptides are not magic bullets. They work best as part of a comprehensive plan that includes proper nutrition, exercise, sleep, and medical oversight.

7. The Peptides people are talking about

We do not prescribe all these peptides nor are they all available through compounding pharmacies. Nor are they appropriate for all patients. Some peptides are extraordinarily safe some are not. Talk to your primary care physician before starting any peptides. Each card explains what the peptide is, how it works, why a physician would reasonably prescribe it, who is and is not a good candidate, and what the published evidence supports. Not every peptide is right for every patient—your protocol is always tailored to your individual labs, health history, and goals.

Video Sources & Independence

The MD videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of peptide mechanisms and clinical considerations. Viewers should evaluate all sources independently.

The Peptides & Hormones — Click Any Card for the Full Guide

Each compound now has its own dedicated page with the complete explanation, published evidence, and recommended physician videos—plus a printable PDF version of that guide.

GLP-1 & Weight Management

Incretin-based medications that reduce appetite, slow gastric emptying, and improve insulin signaling. The most extensively studied weight-loss medications in modern medicine.

Growth Hormone Support

Peptides and secretagogues that stimulate the pituitary to release your own growth hormone in a physiologic pattern—rather than injecting exogenous GH, which bypasses the body's natural feedback mechanisms.

Tissue Repair & Recovery

Peptides discussed for tendon, ligament, muscle, mucosal, and barrier healing. The evidence base is heavily preclinical, so the honest conversation matters.

Immune Support

Peptides that modulate immune function—not a "boost," but a targeted signal that requires the same specificity as any other immune-active therapy.

Anti-Aging, Skin & Cellular Repair

Compounds discussed for skin quality, wound healing, telomere biology, and cellular maintenance. Route of administration matters as much as the compound itself.

Sexual Health

Melanocortin-based therapy that works through the central nervous system, not the vascular system—useful for a specific subset of patients.

Fat Metabolism & Metabolic Support

Adjunct peptides and coenzymes that target fat oxidation and cellular energy pathways. Meaningful when framed correctly, disappointing when oversold.

Cognitive & Neurological Support

A group of compounds with substantial international use and research literature but limited or no U.S. clinical prescribing pathway. Interesting science; extra regulatory caution required.

Hormone Therapies

Classic prescription hormone programs offered under physician supervision, with decades of clinical use and well-characterized monitoring requirements.

The Peptide Landscape at a Glance

The compounds discussed above fall into several broad clinical categories. Each category has its own evidence base, its own safety profile, and its own patient-selection considerations.

Regulatory Climate & Making Informed Choices

A Note on the Regulatory Climate

The peptide therapy landscape continues to evolve. Some peptides have full FDA approval. Others are available through licensed compounding pharmacies under current regulations. Still others exist in a regulatory grey area.

We strongly encourage every patient to conduct their own exhaustive research before pursuing any peptide therapy. We do not recommend purchasing peptides from online research-chemical vendors or unverified sources.

We are not anti-pharmaceutical industry. Large pharmaceutical companies have developed many important and life-changing medicines. At the same time, we believe patients benefit from transparency about the full picture — including publicly documented cases of large fines, lawsuits, political contributions, and the movement of officials between regulatory agencies and industry.

Our approach is one of common-sense healthcare choices. We work exclusively with licensed U.S. compounding pharmacies, require medical evaluation and ongoing oversight, and adjust protocols as regulations change.

📄 Download PDF version

GLP-1 Medications

A Patient Education Guide: How They Work, What to Expect, and What to Consider

1. What Are GLP-1 Medications, and How Do They Work?

GLP-1 medications have become one of the most significant developments in weight management and metabolic health in recent years. Understanding how they work — and how the different types differ — helps explain why some patients respond differently to each option.

How GLP-1 Medications Work

GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces in the gut after eating. Naturally-occurring GLP-1 does several things: it signals your brain that you're full, slows down how quickly your stomach empties, and helps your pancreas release the right amount of insulin in response to food.

GLP-1 medications are designed to mimic and amplify this natural hormone, but with a much longer-lasting effect than your body's own GLP-1 (which breaks down within minutes). By activating GLP-1 receptors continuously, these medications produce sustained appetite suppression, slower digestion, and improved blood sugar regulation — which is why they were originally developed for type 2 diabetes before their weight-loss effects became widely recognized.

The Two Main Types

Semaglutide (Ozempic, Wegovy)

Semaglutide was the medication that brought this drug class into mainstream awareness. It works as a single-mechanism GLP-1 receptor agonist — meaning it activates only the GLP-1 receptor pathway. It remains highly effective for many patients and has the longest track record of real-world use among this newer generation of medications.

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide takes things a step further by activating two receptor pathways instead of one: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). GIP is another gut hormone involved in insulin regulation and fat metabolism. This dual-agonist approach is part of why tirzepatide often produces greater average weight loss than semaglutide, and why some patients who plateau on semaglutide see renewed results when switching to tirzepatide.

The Bigger Picture

Each additional receptor pathway — from one (semaglutide) to two (tirzepatide) — represents an attempt to hit more of the body's natural metabolic signaling systems at once. In general, this has correlated with greater average weight loss across the class, but it also means more variables to consider around side effects, cost, and how established the safety data is for each option.

2. Why GLP-1 Medications Sometimes “Suddenly Stop Working”

Patients often assume they got a bad batch when their GLP-1 medication stops producing appetite suppression or weight loss effects after months of steady results. In most cases, what's actually happening is receptor adaptation, not a defective product.

The Mechanism

GLP-1 receptor agonists work by binding to and activating GLP-1 receptors in the brain (hypothalamus) and gut. At a fixed dose, the body's receptors can downregulate over time — becoming less responsive to the same concentration of drug. Early on, a 1 mg dose might fully saturate and activate enough receptors to produce strong appetite suppression. But as the body adapts, that same 1 mg dose no longer produces the same signal — not because the drug degraded, but because the receptor response threshold shifted.

Why It Feels Sudden Rather Than Gradual

Receptor sensitivity often doesn't decline in a smooth, linear fashion — it can behave more like a threshold effect. The patient feels normal appetite suppression right up until the point where remaining receptor activation drops below what's needed to produce a noticeable clinical effect. From the patient's perspective, this shows up as “it worked fine last week and now it's like I'm not taking anything,” which understandably reads as a supply or quality problem rather than a pharmacodynamic one.

Why the Dose Ceiling Matters

The approved maximum doses (2.4 mg for semaglutide, higher tiers for tirzepatide) exist precisely because this adaptation is expected. A patient plateauing at 1 mg still has significant room — more than double — before they've exhausted the dosing range. Titrating up is the standard, evidence-based response to a plateau; it isn't a sign of drug failure.

The Behavioral Trap

Because “bad batch” feels like a supply-chain problem, patients often respond by switching pharmacies or suppliers rather than revisiting their dose with their prescriber. This can lead to unnecessary compounding-pharmacy shopping, delays in care, and in some cases abandoning an otherwise effective medication entirely — when the actual fix is a routine dose adjustment within the approved range.

3. Muscle Loss and Premature Aging: The Overlooked Side Effect of Weight Loss

Losing weight and losing muscle often happen together — and muscle loss is what quietly ages you, both in function and in appearance.

The Muscle Problem

Aggressive dieting, especially without enough protein or resistance training, burns through lean muscle along with fat. This adds to a process already underway: starting around age 20, everyone experiences sarcopenia, a gradual, ongoing decline in muscle mass and strength that continues for decades and has been formally recognized as a disease (ICD-10 code M62.84). Combine natural sarcopenia with diet-driven muscle loss, and by their 50s, many patients have lost far more muscle than they realize — leaving them lighter on the scale but weaker and less resilient than they were years earlier.

The Documented Link to Mobility and Longevity

This isn't just a cosmetic concern — it's well established in the medical literature:

  • A meta-analysis spanning over 42,000 participants across multiple studies confirmed sarcopenia's association with mortality across community-dwelling adults, outpatients, inpatients, and nursing home residents.
  • A large Chinese cohort study found that sarcopenia was associated with meaningfully higher odds of death over 7 years of follow-up, with the risk more than doubling for severe sarcopenia — and the relative mortality risk was actually highest in the 45–60 age group.
  • Research on hospitalized elderly patients found that sarcopenia was significantly associated with higher mortality specifically among patients with limited mobility and degraded functional abilities, regardless of age. Among those with lower autonomy scores, the risk of death was up to 3.63 times higher in sarcopenic patients.
  • A longitudinal study using Chinese health data set out to estimate sarcopenia-specific life expectancy, noting sarcopenia's well-established association with mortality, falls, physical disability, and poor quality of life.
  • A Japanese population study found sarcopenia carried more than double the hazard of all-cause mortality compared to those without it, concluding that a public health strategy for sarcopenia is needed to extend healthy life expectancy.

The pattern across this research is consistent: less muscle mass correlates with reduced mobility, greater functional decline, and shorter life expectancy — independent of many other health factors.

Why It Shows Up on Your Face

Muscle loss isn't limited to arms, legs, and core — it affects facial musculature too. The muscle beneath the skin that gives a face its shape and structure diminishes along with muscle everywhere else. This is a major, underappreciated reason people who lose significant weight often look older rather than simply slimmer: without the underlying muscle support, skin appears looser, features appear more sunken, and the face takes on a prematurely aged look.

Where Diet and Exercise Fall Short

Protein intake and resistance training are essential and effective for building and preserving skeletal muscle — but they have limited reach into facial muscle and don't directly address the hormonal decline (particularly falling growth hormone levels) that drives much of this aging process from the inside out.

An Option Worth Exploring

Growth hormone-releasing peptides work by stimulating your body's own natural GH production. They're not all FDA-approved for this specific use, and the evidence varies by peptide — but interest has grown rapidly, with tens of thousands of people across TikTok, YouTube, Reddit, and Facebook reporting visible improvements in muscle tone, facial fullness, and overall youthfulness.

Curious if this is right for you? Contact a member of our staff for a personalized assessment.

4. Thinking About Switching GLP-1 Medications? Things to Consider

If your current medication has stopped working, or side effects are becoming difficult to manage, you may be exploring your options. Here's what's worth knowing about the path from semaglutide (Ozempic/Wegovy) to tirzepatide (Mounjaro/Zepbound).

Semaglutide (Ozempic/Wegovy)

This is often the starting point. If it worked well for a period of time and then plateaued, that's frequently a dosing issue rather than a reason to switch medications entirely — many patients find success simply titrating up before considering a different drug.

Tirzepatide (Mounjaro/Zepbound)

This is a reasonable next step when:

  • Semaglutide has genuinely stopped producing results even at higher doses
  • Side effects on semaglutide (nausea, GI upset) are becoming intolerable rather than mild, and adjusting the dose hasn't helped
  • You've discussed with your provider that a dual-mechanism medication may work differently for your body

Newer medications in this class are generally designed with an eye toward improved tolerability, so some patients do experience fewer side effects on tirzepatide even at comparable effectiveness levels — though individual response varies.

On Cost

This is worth factoring in either direction:

  • Newer medications (tirzepatide) tend to carry a higher price tag, at least initially
  • At the same time, semaglutide and tirzepatide prices have both dropped significantly in recent months, which may make “staying the course” with a dose adjustment more attractive than switching, especially if cost is a factor in your decision

The Bottom Line

Whether a plateau, side effects, or something else is driving the conversation, it's worth separating three different questions: is this a dosing problem, a tolerability problem, or a genuine non-response to the mechanism itself? Each points toward a different next step, and working through that with your provider before switching often saves both time and money.

This guide is for general educational purposes and is not a substitute for individualized medical advice. Please consult with a licensed provider to determine the best treatment approach for your specific situation. For questions, use the contact options below.